PRESS RELEASE published on 07/18/2025 at 11:57, 1 year ago PharmaSGP Holding SE: Acceptance period for FUTRUE GmbH’s public delisting tender offer underway PharmaSGP Holding SE announces FUTRUE GmbH's public delisting tender offer acceptance period. Shareholders can tender shares for €28.00 cash consideration until August 11, 2025 Shareholders Tender Offer Delisting Cash Consideration PharmaSGP Holding SE
BRIEF published on 07/11/2025 at 08:06, 1 year ago PharmaSGP Holding SE révise ses prévisions de chiffre d'affaires pour 2025 EBITDA Ajusté Ajustement Des Revenus PharmaSGP Prévisions Pour 2025 Incertitude Géopolitique
BRIEF published on 07/11/2025 at 08:06, 1 year ago PharmaSGP Holding SE Revises 2025 Revenue Forecast Adjusted EBITDA Revenue Adjustment PharmaSGP 2025 Forecast Geopolitical Uncertainty
PRESS RELEASE published on 07/11/2025 at 08:01, 1 year ago EQS-Adhoc: PharmaSGP Holding SE adjusts its revenues forecast for the full year 2025 PharmaSGP Holding SE adjusts full year 2025 revenue forecast due to current data evaluation. Adjusted forecast now €132.0-138.0 million. EBITDA expectation maintained EBITDA Revenue Forecast PharmaSGP Holding SE Adjusted Forecast 2025 Fiscal Year
BRIEF published on 06/26/2025 at 12:44, 1 year ago PharmaSGP Holding SE tient son assemblée générale annuelle en 2025 Résultats Financiers Politique De Dividendes PharmaSGP Prévisions Pour 2025 Assemblée Annuelle
BRIEF published on 06/26/2025 at 12:44, 1 year ago PharmaSGP Holding SE Holds Annual General Meeting 2025 Financial Results Dividend Policy Annual Meeting PharmaSGP 2025 Forecast
PRESS RELEASE published on 06/26/2025 at 12:39, 1 year ago PharmaSGP Holding SE holds 2025 Annual General Meeting PharmaSGP Holding SE reports on 2025 Annual General Meeting, with 91.12% share capital represented, €0.05 dividend per share approved, and confirmation of 2025 fiscal year forecast Annual General Meeting Dividend Forecast PharmaSGP Holding SE OTC Pharmaceuticals
BRIEF published on 06/18/2025 at 17:34, 1 year 1 month ago PharmaSGP SE to Redeem Shares Amid Upcoming Delisting Treasury Shares Delisting Squeeze-out Share Redemption PharmaSGP
BRIEF published on 06/18/2025 at 17:34, 1 year 1 month ago PharmaSGP SE va racheter ses actions dans le cadre de sa prochaine radiation de la cote Actions Propres Rachat D'actions Radiation PharmaSGP Retrait Forcé
PRESS RELEASE published on 06/18/2025 at 17:29, 1 year 1 month ago PharmaSGP SE plans to redeem own shares – conditions for squeeze-out under conversion law are met PharmaSGP SE plans to redeem treasury shares to optimize use of new authorization, leading to a squeeze-out possibility due to increased ownership percentage Share Buyback Treasury Shares Squeeze-out PharmaSGP Conversion Law
Published on 07/22/2026 at 03:10, 22 minutes ago High Tide Resources Corp. Announces Change of Auditor
Published on 07/22/2026 at 02:30, 1 hour 2 minutes ago Avidian Gold Corp. Announces Change of Auditor
Published on 07/21/2026 at 23:00, 4 hours 32 minutes ago Viemed Healthcare Announces Second Quarter 2026 Earnings Conference Call Details
Published on 07/21/2026 at 22:30, 5 hours 2 minutes ago Fermi Announces First Siemens Turbines Arrive at Port of Houston
Published on 07/21/2026 at 22:30, 5 hours 2 minutes ago Matador Technologies Announces Management Transition
Published on 07/22/2026 at 01:05, 2 hours 27 minutes ago Quantinuum and SoftBank Corp. Publish Joint White Paper on Scaling Practical Quantum Computing Use Cases Toward the Fault-Tolerant Era
Published on 07/21/2026 at 22:30, 5 hours 2 minutes ago Strong second quarter: GEA raises full-year guidance for 2026
Published on 07/21/2026 at 22:16, 5 hours 16 minutes ago EQS-Adhoc: GEA Group Aktiengesellschaft: Preliminary numbers for Q2 2026 exceed market expectation - increase of guidance for fiscal year 2026
Published on 07/21/2026 at 18:50, 8 hours 42 minutes ago Soapeya, a DN Group AG Portfolio Company, Earns Top "Excellent" Rating from Dermatest and Proves Successful in Field Use in Ghana
Published on 07/21/2026 at 18:15, 9 hours 17 minutes ago EuroTeleSites Reports Strong Q2/2026 Results with Growth Across Key Financial and Operating Metrics
